title: Gender Differences in Psychiatric Symptoms among Methamphetamine Dependent Residents in Sober Living Houses.
abstract: Although psychiatric symptoms among methamphetamine (MA) dependent individuals have been studied in treatment programs, they have not been examined in services designed to support sustained recovery in the community (e.g. sober living houses). In addition, some disorders more common among women, such as somatoform and bulimia, have been understudied among MA dependent individuals. This study aimed to examine psychiatric symptom differences between MA dependent men and women who we entering sober living houses (SLHs).
  
  
  
  Two hundred forty five individuals were interviewed within one week of entering SLHs. Instruments included a DSM IV based measure for MA dependence, a psychiatric screen (the Psychiatric Diagnostic Screening Questionnaire), demographics, recent substance use and recent use of services.
  
  
  
  Of the 245 participants, 103 men and 25 women met criteria for MA dependence. Womenwith MA dependence reported more psychiatric symptoms than men. They also trended toward reporting more psychiatric symptoms than non-MA dependent women. For men, psychiatric symptoms did not vary between those with and without MA dependence. Some understudied disorders (e.g., somatoform) had large proportions of women meeting the screening criteria.
  
  
  
  Additional research is needed on understudied psychiatric disorders that are common among MA dependent women. SLH's should consider ways to address psychiatric symptoms among MA dependent individuals, especially women. Strategies could include increasing linkages with professional mental health services as well as developing peer oriented strategies for managing symptoms.
authors.affiliation: Alcohol Research Group Public Health Institute 6475 Christie Avenue, Suite 400 Emeryville, CA 94608-1010 Phone (510) 597-3440 Fax (510) 985-6459.
authors.forename: Douglas L
authors.initials: DL
authors.lastname: Polcin
authors.forename: Raymond
authors.initials: R
authors.lastname: Buscemi
authors.forename: Madhabika
authors.initials: M
authors.lastname: Nayak
authors.forename: Rachael
authors.initials: R
authors.lastname: Korcha
authors.forename: Gantt
authors.initials: G
authors.lastname: Galloway
keywords: Methamphetamine; co-morbidity; gender differences; psychiatric symptoms; sober living houses
references.citation: J Psychiatry Neurosci. 2006 Sep;31(5):301-13
references.pmid: 16951733
references.citation: Arch Gen Psychiatry. 2004 Aug;61(8):807-16
references.pmid: 15289279
references.citation: Subst Use Misuse. 2007;42(14):2207-22
references.pmid: 18098001
references.citation: Gend Med. 2008 Mar;5(1):24-35
references.pmid: 18420163
references.citation: J Nerv Ment Dis. 2005 Jul;193(7):431-7
references.pmid: 15985836
references.citation: Am J Psychiatry. 1996 Jun;153(6):812-5
references.pmid: 8633695
references.citation: J Trauma. 2009 Feb;66(2):485-90
references.pmid: 19204525
references.citation: Am J Psychiatry. 2003 May;160(5):890-5
references.pmid: 12727692
references.citation: Arch Gen Psychiatry. 2001 Aug;58(8):787-94
references.pmid: 11483146
references.citation: J Psychoactive Drugs. 2008 Jun;40(2):153-9
references.pmid: 18720664
references.citation: Am J Addict. 2004 Mar-Apr;13(2):181-90
references.pmid: 15204668
references.citation: J Subst Abuse Treat. 2008 Dec;35(4):445-50
references.pmid: 18294802
references.citation: Drug Alcohol Depend. 2006 Feb 28;81(3):301-12
references.pmid: 16169159
references.citation: J Psychoactive Drugs. 2007 Nov;Suppl 4:367-81
references.pmid: 18284103
references.citation: J Subst Abuse Treat. 2005 Jan;28(1):77-85
references.pmid: 15723735
references.citation: Am J Addict. 2000 Spring;9(2):113-25
references.pmid: 10934573
references.citation: JAMA. 2005 Oct 26;294(16):2009-10
references.pmid: 16249405
references.citation: Addiction. 2007 Jul;102(7):1102-13
references.pmid: 17567398
references.citation: Addiction. 2006 Oct;101(10):1473-8
references.pmid: 16968349
references.citation: Gen Dent. 2006 Mar-Apr;54(2):125-9; quiz 130
references.pmid: 16689071
references.citation: Am J Addict. 2003 Oct-Dec;12(5):377-85
references.pmid: 14660152
references.citation: Am Surg. 2007 Oct;73(10):1044-6
references.pmid: 17983078
references.citation: J Subst Abuse Treat. 2005 Mar;28(2):189-96
references.pmid: 15780549
references.citation: Addiction. 2007 Apr;102 Suppl 1:84-95
references.pmid: 17493057
references.citation: Am J Addict. 2003 Oct-Dec;12(5):412-23
references.pmid: 14660155
references.citation: J Psychoactive Drugs. 1996 Jan-Mar;28(1):95-102
references.pmid: 8714338
references.citation: Drug Alcohol Depend. 2007 Jul 10;89(2-3):267-74
references.pmid: 17329040
references.citation: J Psychoactive Drugs. 2007 Nov;Suppl 4:353-66
references.pmid: 18284102
references.citation: J Psychoactive Drugs. 2000 Apr-Jun;32(2):221-8
references.pmid: 10908011
references.citation: J Trauma. 2007 Sep;63(3):531-7
references.pmid: 18073597
references.citation: Subst Use Misuse. 1997 May;32(6):653-78
references.pmid: 9178435
references.citation: Addict Behav. 2004 Jan;29(1):89-106
references.pmid: 14667423
references.citation: Drug Alcohol Depend. 2000 Feb 1;58(1-2):9-25
references.pmid: 10669051
references.citation: J Psychoactive Drugs. 2007 Nov;Suppl 4:347-51
references.pmid: 18284101
references.citation: Ann N Y Acad Sci. 2000 Sep;914:292-302
references.pmid: 11085329
references.citation: J Psychoactive Drugs. 2006 Jun;38(2):189-202
references.pmid: 16903458